Age-related macular degeneration: current treatments

References

• KahnHALeibowitzHMGanleyJPThe Framingham Eye Study. I. Outline and major prevalence findingsAm J Epidemiol197710611732879158
   PubMed Web of Science ®Google Scholar
• KleinBELintonKLPrevalence of age-related maculopathy. The Beaver Dam Eye StudyOphthalmology1992996933431630784
   PubMed Web of Science ®Google Scholar
• KleinBEKleinRCataracts and macular degeneration in older AmericansArch Ophthalmol1982100457137073566
   PubMedGoogle Scholar
• MitchellPSmithWAtteboKWangJJPrevalence of age-related maculopathy in Australia The Blue Mountains Eye StudyOphthalmology1995102101450609097791
   PubMed Web of Science ®Google Scholar
• Complications of Age-Related Macular Degeneration Prevention Trial Study GroupThe Complications of Age-Related Macular Degeneration Prevention Trial (CAPT):rationale, design and methodologyClin Trials200419110716281465
   PubMedGoogle Scholar
• FriedmanDSO’ColmainBJMunozBEye Diseases Prevalence Research Group, 2004Prevalence of age-related macular degeneration in the United StatesArch Ophthalmol200412245647215078675
   PubMed Web of Science ®Google Scholar
• ThyleforsBA global initiative for the elimination of avoidable blindnessAm J Ophthalmol1998125190939437318
   PubMed Web of Science ®Google Scholar
• BresslerNMBresslerSBFineSLAge-related macular degenerationSurv Ophthalmol19883263754132457955
   PubMed Web of Science ®Google Scholar
• VotrubaMGregorZNeovascular age-related macular degeneration: present and future optionsEye20011534242911450768
   PubMed Web of Science ®Google Scholar
• MichelsSSchmidt-ErfurthURosenfeldPJPromising new treatments for neovascular age-related macular degenerationExpert Opin Investig Drugs200615777993
   PubMedGoogle Scholar
• A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss:AREDS report no. 8Arch Ophthalmol200111914173611594942
   PubMed Web of Science ®Google Scholar
• OmennGSGoodmanGEThornquistMDEffects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular diseaseN Engl J Med1996334115058602180
   PubMed Web of Science ®Google Scholar
• The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study GroupN Engl J Med19943301029358127329
   PubMed Web of Science ®Google Scholar
• ObanaAHiramitsuTGohtoYMacular carotenoid levels of normal subjects and age-related maculopathy patients in a Japanese populationOphthalmology200811511475718166409
   PubMed Web of Science ®Google Scholar
• ChewEYSanGiovanniJPLutein Encyclopedia of Dietary SupplementsMarcel Dekker, Inc200540920
   Google Scholar
• SanGiovanniJPChewEYThe role of omega-3 LCPFA in health and disease of the retinaProg Retin Eye Res20052418713815555528
   PubMed Web of Science ®Google Scholar
• SeddonJMCoteJRosnerBProgression of age-related macular degeneration:Association with dietary fat, transunsaturated fat, nuts, and fish intakeArch Ophthalmol20031211217283714662593
   PubMedGoogle Scholar
• SanGiovanniJPChewEYClemonsTESeddonJMKleinRAge-Related Eye Disease Study (AREDS) Research GroupDietary lipids intake and incident advanced Age-Related Macular Degeneration (AMD) in the Age-Related Eye Disease Study (AREDS)Annual MeetingMay 2005Association for Research in Vision and Ophthalmology (ARVO)Fort Lauderdale, FL
   Google Scholar
• Macular Photocoagulation Study GroupArgon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trialsArch Ophthalmol19911091109141714270
   PubMed Web of Science ®Google Scholar
• Macular Photocoagulation Study GroupLaser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trialsArch Ophthalmol199411250097512336
   PubMedGoogle Scholar
• Macular Photocoagulation Study GroupLaser photocoagulation of sub-foveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trialsArch Ophthalmol19931111200097689827
   PubMed Web of Science ®Google Scholar
• Macular Photocoagulation Study GroupLaser photocoagulation of sub-foveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trialArch Ophthalmol19911091220311718250
   PubMed Web of Science ®Google Scholar
• Macular Photocoagulation Study GroupLaser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration. Results of a randomized clinical trialArch Ophthalmol19911091232411718251
   PubMedGoogle Scholar
• Argon laser photocoagulation for neovascular maculopathyFive-year results from randomized clinical trials. Macular Photocoagulation Study GroupArch Ophthalmol19911091109141714270
   PubMedGoogle Scholar
• CiullaTACriswellMHDanisRPWilliamsJIMcLaneMPHolroydKJSqualamine lactate reduces choroidal neovascularization in a laser-injury model in the ratRetina20032368081414707832
   PubMed Web of Science ®Google Scholar
• CiullaTARegilloCDesaIA phase II, multi-center, randomized, controlled, masked study of the effects of squalamine lactate in combination with Visudyne in patient with subfoveal neovascularization associated with AMDARVOFort Lauderdale2005
   Google Scholar
• Schmidt-ErfurthULaquaHSchlotzer-ShrehardUViestenzANaumannGOHistopathological changes following photodynamic therapy in human eyesArch Ophthalmol200212068354412049594
   PubMedGoogle Scholar
• Schmidt-ErfurthUSchlötzer-SchrehardUCursiefenCMichelsSBeckendorfANaumannGOInfluence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF Receptor 3, and pigment epithelium – derived factorInvest Ophthalmol Vis Sci2003441044738014507895
   PubMed Web of Science ®Google Scholar
• BresslerNMBresslerSBFineSLAge-related macular degenerationSurv Ophthalmol1988323754132457955
   PubMed Web of Science ®Google Scholar
• BresslerNMPhotodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin:two-year results of 2 randomized clinical trials-TAP report 2Arch Ophthalmol200111919820711176980
   PubMed Web of Science ®Google Scholar
• Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin:one-year results of 2 randomized clinical trials – TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study GroupArch Ophthalmol199911713294510532441
   PubMed Web of Science ®Google Scholar
• Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration:two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization – verteporfin in photodynamic therapy report 2Am J Ophthalmol20011315416011336929
   PubMed Web of Science ®Google Scholar
• WormaldREvansJSmeethLHenshawKPhotodynamic therapy for neovascular age-related macular degenerationCochrane Database Syst Rev2007183
   Google Scholar
• ArnoldJJBlinderKJBresslerNMTreatment of Age-Related Macular Degeneration with Photodynamic Therapy Study Group; Verteporfin in Photodynamic Therapy Study Group. Acute severe visual acuity disease after photodynamic therapy with verteporfin:case reports from randomized clinical trials-TAP and VIP report no. 3Am J Ophthalmol200413746839615059708
   PubMed Web of Science ®Google Scholar
• BlinderKJBradleySBresslerNMEffect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration:TAP and VIP report no. 1Am J Ophthalmol20031364071812967792
   PubMed Web of Science ®Google Scholar
• MeyerMClaussMLepple-WienhuesAA novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinasesEMBO J1999182363749889193
   PubMed Web of Science ®Google Scholar
• CampochiaroPARetinal and choroidal neovascularizationJ Cell Physiol200018433011010911360
   PubMed Web of Science ®Google Scholar
• KustersBde WaalRMWesselingPDifferential effects of vascular endothelial growth factor A isoforms in a mouse brain metastasis model of human melanomaCancer Res2003631754081314500375
   PubMed Web of Science ®Google Scholar
• SpyridopoulosILuedemannCChenDKearneyMChenDMuroharaTPrincipeNIsnerJMLosordoDWDivergence of angiogenic and vascular permeability signaling by VEGF:inhibition of protein kinase C suppresses VEGF-induced angiogenesis, but promotes VEGF-induced, NO-dependent vascular permeabilityArterioscler Thromb Vasc Biol2002226901612067896
   PubMed Web of Science ®Google Scholar
• FerraraNKerbelRSAngiogenesis as a therapeutic targetNature20054389677416355214
   PubMed Web of Science ®Google Scholar
• FerraraNGerberHPLeCouterJThe biology of VEGF and its receptorsNat Med2003966697612778165
   PubMed Web of Science ®Google Scholar
• MoshfeghiAAPuliafitoCAPegaptanib sodium for the treatment of neovascular age-related macular degenerationExpert Opin Investig Drugs200514567182
   PubMed Web of Science ®Google Scholar
• GragoudasESAdamisAPCunninghamETJrFeinsodMGuyerDRVEGF Inhibition Study in Ocular Neovascularization Clinical Trial GroupN Engl J Med20043512728051615625332
   PubMed Web of Science ®Google Scholar
• VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial GroupChakravarthyUAdamisAPCunninghamETJrYear 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degenerationOphthalmology2006113915082516828500
   PubMed Web of Science ®Google Scholar
• GonzalesCRVEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial GroupEnhanced efficacy associated with early treatment of neovascular age-related macular degeneration with pegaptanib sodium:an exploratory analysisRetina20052578152716205558
   PubMed Web of Science ®Google Scholar
• ChenYWiesmannCFuhGSelection and analysis of an optimized anti-VEGF antibody:crystal structure of an affinity-matured Fab in complex with antigenJ Mol Biol199929348658110543973
   PubMed Web of Science ®Google Scholar
• Schmidt-ErfurthUResults from the PIER studyPresented at Asian Pacific Association of Ophthalmologists Annual Meeting (APAO)June 2006Singapore
   Google Scholar
• BrownDMKaiserPKMichelsMfor the ANCHOR Study Group2006. Ranibizumab versus verteporfin for neovascular age-related macular degenerationN Engl J Med200635514324417021319
   PubMed Web of Science ®Google Scholar
• ChangTSFineJTBresslerNMSelf-reported Vision-specific Quality of Life at 1 Year in Patients with Neovascular Age-related Macular Degeneration in 2 Phase III Randomized Clinical Trials Of Ranibizumab (Lucentis). IOVS, ARVO 2004. Abstract 5252.
   Google Scholar
• RosenfeldPJBrownDMHeierJSMARINA Study GroupRanibizumab for neovascular age-related macular degenerationN Engl J Med20063551414193117021318
   PubMed Web of Science ®Google Scholar
• FungAELalwaniGARosenfeldPJAn optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degenerationAm J Ophthalmol200714345668317386270
   PubMed Web of Science ®Google Scholar
• BrownDMRegilloCDAnti-VEGF Agents in the treatment of neovascular age-related macular degeneration:applying clinical trial results to the treatment of everyday patientsAm J Ophthalmol200714446273717893015
   PubMed Web of Science ®Google Scholar
• MichelsSRosenfeldPJPuliafitoCASystemic bevacizumab (Avastin) therapy for Neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical studyOphthalmology200511210354715936441
   PubMed Web of Science ®Google Scholar
• BarkerDLBrooksHLSteinmetzRLNewellCKPuliafitoCARosenfeldPJIntravitreal bevacizumab compared with photodynamic therapy for juxtafoveal choroidal neovascular membranes in age related macular degeneration. Abstract:ASRS. EVRS Cannes Retina Festival 2006, France, September 8–13.
   Google Scholar
• RichRMRosenfeldPJPuliafitoCAShort-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degenerationRetina200626549551116770255
   PubMed Web of Science ®Google Scholar
• SpaideRFLaudKFineHFIntravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degenerationRetina2006263839016603955
   PubMed Web of Science ®Google Scholar
• WilliamsDFBennettSRCantrillHLIntravitreal bevacizumab (Avastin®) for primary treatment of neovascular AMD. Abstract: ASRS. EVRS Cannes Retina Festival 2006, France, September 8–13.
   Google Scholar
• AveryRLPieramiciDJRabenaMDCastellarinAANasirMAGiustMJIntravitreal bevacizumab (Avastin) for neovascular age-related macular degenerationOphthalmology20061133637216458968
   PubMed Web of Science ®Google Scholar
• ShaharJAveryRLHeilweilGElectrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin)Retina2006263262916508424
   PubMed Web of Science ®Google Scholar
• ChangLKSarrafDTears of the retinal pigment epithelium:an old problem in a new eraRetina200;2755233417558312
   PubMed Web of Science ®Google Scholar
• ChanCKLinSGRetinal pigment epithelial tear after ranibizumab therapy for subfoveal fibrovascular pigment epithelial detachmentEur J Ophthalmol200;174674617671950
   PubMed Web of Science ®Google Scholar
• RonanSMYoganathanPChienFYRetinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degenerationRetina200;2755354017558313
   PubMed Web of Science ®Google Scholar
• SpandauUHJonasJBRetinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degenerationAm J Ophthalmol2006142610687017157597
   PubMed Web of Science ®Google Scholar
• WeinbergerAWThielMMohammadiBTheofylaktopoulosITGWalterPRetinal pigment epithelium tears after intravitreal bevacizumab in pigment epithelium detachmentAm J Ophthalmol20071442294617659961
   PubMed Web of Science ®Google Scholar
• GilliesMCWongTYRanibizumab for neovascular age-related macular degenerationN Engl J Med200735677489author reply 7495017310523
   PubMed Web of Science ®Google Scholar
• WongTYLiewGMitchellPClinical update:new treatments for age-related macular degenerationLancet20073709583204617658379
   PubMed Web of Science ®Google Scholar
• Schmidt-ErfurthUSchlotzer-SchrehardUCursiefenCMichelsSBeckendorfANaumannGOInfluence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factorInvest Ophthalmol Vis Sci200344104738012556371
   PubMed Web of Science ®Google Scholar
• KaiserPKVerteporfin therapy in combination with triamcinolone: published studies investigating a potential synergistic effectCurr Med Res Opin20052157051315969870
   PubMed Web of Science ®Google Scholar
• RechtmanEDanisRPPrattLMHarrisAIntravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degenerationBr J Ophthalmol2004883344714977766
   PubMed Web of Science ®Google Scholar
• SpaideRFSorensonJMarananLCombined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularizationOphthalmology2003110815172512917166
   PubMed Web of Science ®Google Scholar
• AugustinAJSchmidt-ErfurthUVerteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degenerationOphthalmology20061131142216360209
   PubMed Web of Science ®Google Scholar
• RussellSRHudsonHLJerdanJAAnecortave Acetate Clinical Study GroupAnecortave acetate for the treatment of exudative age-related macular degeneration – a review of clinical outcomesSurv Ophthalmol2007527990
   Web of Science ®Google Scholar
• RegilloCDD’AmicoDJMielerWFSchneebaumCBeasleyCHSullinsGTClinical safety profile of posterior juxtascleral depot administration of anecortave acetate 15 mg suspension as primary therapy or adjunctive therapy with photodynamic therapy for treatment of wet age-related macular degenerationSurv Ophthalmol200752708
   Web of Science ®Google Scholar
• KaiserPKVerteporfin photodynamic therapy and anti-angiogenic drugs:potential for combination therapy in exudative age-related macular degenerationCurr Med Res Opin20072334778717355729
   PubMed Web of Science ®Google Scholar
• PetermeierKTatarOInhoffenWVerteporfin photodynamic therapy induced apoptosis in choroidal neovascular membranesBr J Ophthalmol20069081034916613924
   PubMed Web of Science ®Google Scholar
• VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial GroupD’AmicoDJMasonsonHNPatelMPegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trialsOphthalmology20061136992100116647134
   PubMed Web of Science ®Google Scholar
• HeierJSBoyerDSCiullaTAFOCUS Study GroupRanibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration:year 1 results of the FOCUS StudyArch Ophthalmol20061241115324217101999
   PubMed Web of Science ®Google Scholar
• Schmidt-ErfurthUGabelPHohmanTPROTECT Study GroupPreliminary results from an open-label, multicenter, phase II study assessing the effects of same-day administration of ranibizumab (Lucentis(TM) and verteporfin PDT (PROTECT Study)Program and abstracts of the Association for Research in Vision and OphthalmologyApril 30-May 4, 2006Fort Lauderdale, FloridaAbstract 2960.
   Google Scholar
• DhallaMSShahGKBlinderKJRyanEHJrMittraRATewariACombined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degenerationRetina20062699889317151484
   PubMed Web of Science ®Google Scholar
• LadewigMSKarlSEHamelmannVCombined intravitreal bevacizumab and photodynamic therapy for neovascular age-related macular degenerationGraefes Arch Clin Exp Ophthalmol2008246172517701197
   PubMed Web of Science ®Google Scholar
• de JuanEJrVitreous surgery for hemorrhagic and fibrous complications of age-related macular degenerationAm J Ophthalmol19881052593337190
   PubMed Web of Science ®Google Scholar
• BergerASKaplanHJClinical experience with the surgical removal of subfoveal neovascular membranes. Short-term postoperative resultsOphthalmology199299696975discussion 97561630786
   PubMed Web of Science ®Google Scholar
• SchachatAPShould we recommend vitreous surgery for patients with choroidal neovascularization?Arch Ophthalmol19941124459617512330
   PubMedGoogle Scholar
• ThomasMADickinsonJDMelbergNSIbanezHEDhaliwalRSVisual results after surgical removal of subfoveal choroidal neovascular membranesOphthalmology199410181384967520148
   PubMed Web of Science ®Google Scholar
• BresslerNMHawkinsBSBresslerSBMiskalaPHMarshMJSubmacular Surgery Trials Research GroupClinical trial performance of community- vs university-based practices in the submacular surgery trials (SST):SST report no. 2Arch Ophthalmol200412268576315197061
   PubMedGoogle Scholar
• FalknerCILeitichHFrommletFBauerPBinderSThe end of submacular surgery for age-related macular degeneration? A meta-analysisGraefes Arch Clin Exp Ophthalmol2007245449050116673139
   PubMed Web of Science ®Google Scholar
• RonYEhrlichRAxer-SiegelRRosenblattIWeinbergerDPneumatic displacement of submacular hemorrhage due to age-related macular degenerationOphthalmologica20072211576117183203
   PubMed Web of Science ®Google Scholar
• SinghRPPatelCSearsJEManagement of subretinal macular haemorrhage by direct administration of tissue plasminogen activatorBr J Ophthalmol20069044293116547320
   PubMed Web of Science ®Google Scholar
• MachemerRSteinhorstUHRetinal separation, retinotomy, and macular relocation:II. A surgical approach for age-related macular degeneration?Graefes Arch Clin Exp Ophthalmol199323111635418258397
   PubMed Web of Science ®Google Scholar
• de JuanEJrLoewensteinABresslerNMAlexanderJTranslocation of the retina for management of subfoveal choroidal neovascularization II:a preliminary report in humansAm J Ophthalmol19981255635469625547
   PubMed Web of Science ®Google Scholar
• LewisHKaiserPKLewisSEstafanousMMacular translocation for subfoveal choroidal neovascularization in age-related macular degeneration: a prospective studyAm J Ophthalmol199912821354610458168
   PubMed Web of Science ®Google Scholar
• EckardtCEckardtUConradHGMacular rotation with and without counter-rotation of the globe in patients with age-related macular degenerationGraefes Arch Clin Exp Ophthalmol199923743132510208265
   PubMed Web of Science ®Google Scholar
• MruthyunjayaPStinnettSSTothCAChange in visual function after macular translocation with 360 degrees retinectomy for neovascular age-related macular degenerationOphthalmology2004111917152415350328
   PubMed Web of Science ®Google Scholar
• TothCAFreedmanSFMacular translocation with 360-degree peripheral retinectomy impact of technique and surgical experience on visual outcomesRetina200121429330311508873
   PubMed Web of Science ®Google Scholar
• TothCALapoliceDJBanksADStinnettSSImprovement in near visual function after macular translocation surgery with 360-degree peripheral retinectomyGraefes Arch Clin Exp Ophthalmol200424275414815185091
   PubMed Web of Science ®Google Scholar
• PertileGClaesCMacular translocation with 360 degree retinotomy for management of age-related macular degeneration with subfoveal choroidal neovascularizationAm J Ophthalmol20021344560512383813
   PubMed Web of Science ®Google Scholar
• MacLarenREUppalGSBalagganKSTufailAMunroPMMillikenABAliRRRubinGSAylwardGWda CruzLAutologous transplantation of the retinal pigment epithelium and choroid in the treatment of neovascular age-related macular degenerationOphthalmology200711435617017324698
   PubMed Web of Science ®Google Scholar
• AisenbreySLafautBASzurmanPIris pigment epithelial translocation in the treatment of exudative macular degeneration: a 3-year follow-upArch Ophthalmol20061242183816476887
   PubMed Web of Science ®Google Scholar
• BinderSStanzelBVKrebsIGlittenbergCTransplantation of the RPE in AMDProg Retin Eye Res2007265516417532250
   PubMed Web of Science ®Google Scholar
• HeussenFMFawzyNFJoeresSLuxAMaaijweeKMeursJCKirchhofBJoussenAMAutologous translocation of the choroid and RPE in age-related macular degeneration:1-year follow-up in 30 patients and recommendations for patient selectionEye2008227999807
   Web of Science ®Google Scholar
• JoussenAMHeussenFMJoeresSAutologous translocation of the choroid and retinal pigment epithelium in age-related macular degenerationAm J Ophthalmol20061421173016815247
   PubMed Web of Science ®Google Scholar
• MaaijweeKHeimannHMissottenTMulderPJoussenAvan MeursJRetinal pigment epithelium and choroid translocation in patients with exudative age-related macular degeneration:long-term resultsGraefes Arch Clin Exp Ophthalmol20072451681917562066
   PubMed Web of Science ®Google Scholar
• CaiHShinMCTezelTHKaplanHJDel PrioreLVUse of iris pigment epithelium to replace retinal pigment epithelium in age-related macular degeneration:a gene expression analysisArch Ophthalmol2006124912768516966623
   PubMed Web of Science ®Google Scholar
• BinderSStolbaUKrebsITransplantation of autologous retinal pigment epithelium in eyes with foveal neovascularization resulting from age-related macular degeneration:a pilot studyAm J Ophthalmol200213322152511812425
   PubMed Web of Science ®Google Scholar
• BinderSKrebsIHilgersRDOutcome of transplantation of autologous retinal pigment epithelium in age-related macular degeneration: a prospective trialInvest Ophthalmol Vis Sci2004451141516015505069
   PubMed Web of Science ®Google Scholar
• Van MeursJCter AverstEHoflandLJAutologous peripheral retinal pigment epithelium translocation in patients with subfoveal neovascular membranesBr J Ophthalmol2004881110314693786
   PubMed Web of Science ®Google Scholar
• KanugaNWintonHLBeauchéneLCharacterization of genetically modified human retinal pigment epithelial cells developed for in vitro and transplantation studiesInvest Ophthalmol Vis Sci2002435465511818403
   PubMed Web of Science ®Google Scholar
• LiYRecaRGAtmaca-SonmezPRatajczakMZIldstadSTKaplanHJEnzmannVRetinal pigment epithelium damage enhances expression of chemoattractants and migration of bone marrow-derived stem cellsInvest Ophthalmol Vis Sci200647416465216565405
   PubMed Web of Science ®Google Scholar
• MangioneCMGutierrezPRLoweGOravEJSeddonJMInfluence of age-related maculopathy on visual functioning and health-related quality of lifeAm J Ophthalmol19991281455310482093
   PubMed Web of Science ®Google Scholar
• LamoureuxELPallantJFPesudovsKHassellJBKeeffeJEThe Impact of Vision Impairment Questionnaire:an evaluation of its measurement properties using Rasch analysisInvest Ophthalmol Vis Sci2006471147324117065481
   PubMed Web of Science ®Google Scholar
• HassellJBLamoureuxELKeeffeJEImpact of age related macular degeneration on quality of lifeBr J Ophthalmol2006905593616622089
   PubMed Web of Science ®Google Scholar
• LamoureuxELPallantJFPesudovsKReesGHassellJBKeeffeJEThe effectiveness of low-vision rehabilitation on participation in daily living and quality of lifeInvest Ophthalmol Vis Sci200748414768217389474
   PubMed Web of Science ®Google Scholar
• MassofRWA system model for low vision rehabilitation. I. Basic conceptsOptom Vis Sci199572107236
   Web of Science ®Google Scholar
• ReevesBCHarperRARussellWBEnhanced low vision rehabilitation for people with age related macular degeneration:a randomised controlled trialBr J Ophthalmol200488111443915489491
   PubMed Web of Science ®Google Scholar
• ScottIUSmiddyWESchiffmanJFeuerWJPappasCJQuality of life of low-vision patients and the impact of low-vision servicesAm J Ophthalmol19991281546210482094
   PubMed Web of Science ®Google Scholar
• SmiddyWERelative cost of a line of vision in age-related macular degenerationOphthalmology200711458475417306878
   PubMed Web of Science ®Google Scholar
• BrownMA value-based medecine analysis of neovascular AMDThe Retina societyBoston92007
   Google Scholar